• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性中枢神经系统淋巴瘤与胶质母细胞瘤的鉴别:灌注加权和扩散加权磁共振成像的联合应用

Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.

作者信息

Makino Keishi, Hirai Toshinori, Nakamura Hideo, Kuroda Jun-Ichiro, Shinojima Naoki, Uetani Hiroyuki, Kitajima Mika, Yano Shigetoshi

机构信息

Department of Neurosurgery, Kumamoto University, Kumamoto, Japan.

Department of Radiology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

出版信息

World Neurosurg. 2018 Apr;112:e1-e6. doi: 10.1016/j.wneu.2017.10.141. Epub 2018 Feb 13.

DOI:10.1016/j.wneu.2017.10.141
PMID:29104150
Abstract

OBJECTIVE

The purpose of this study was to determine whether combined diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging magnetic resonance imaging can be used to differentiate between common malignant brain tumors, including lymphomas and high-grade gliomas.

METHODS

We evaluated 87 patients with histologically confirmed brain tumors, including 33 primary central nervous system lymphomas (PCNSLs) and 54 glioblastomas (GBMs). All patients underwent conventional magnetic resonance imaging, diffusion-weighted imaging, and perfusion-weighted imaging before surgical removal of the lesion or stereotactic biopsy.

RESULTS

The maximum relative cerebral blood volume (rCBV) ratios of GBMs were significantly higher than those of PCNSLs (P < 0.0001). The maximum rCBVs helped to distinguish PCNSLs from GBMs with 97.0% sensitivity, 90.7% specificity, and 0.98 area under the curve. The minimum apparent diffusion coefficients (ADCs) of PCNSLs were significantly lower than those of GBMs (P < 0.0001). At an rCBV cutoff value of 4.0 and a minimum ADC of 1.0 × 10 mm/second, it was possible to differentiate between PCNSLs and GBMs.

CONCLUSIONS

The combination of rCBV and ADC can facilitate the differentiation between PCNSLs and GBMs.

摘要

目的

本研究的目的是确定联合扩散加权成像和动态磁敏感对比增强灌注加权成像磁共振成像是否可用于鉴别常见的恶性脑肿瘤,包括淋巴瘤和高级别胶质瘤。

方法

我们评估了87例经组织学证实的脑肿瘤患者,包括33例原发性中枢神经系统淋巴瘤(PCNSL)和54例胶质母细胞瘤(GBM)。所有患者在手术切除病变或立体定向活检前均接受了常规磁共振成像、扩散加权成像和灌注加权成像。

结果

GBM的最大相对脑血容量(rCBV)比值显著高于PCNSL(P < 0.0001)。最大rCBV有助于区分PCNSL和GBM,灵敏度为97.0%,特异性为90.7%,曲线下面积为0.98。PCNSL的最小表观扩散系数(ADC)显著低于GBM(P < 0.0001)。在rCBV临界值为4.0且最小ADC为1.0×10⁻³mm²/秒时,可以区分PCNSL和GBM。

结论

rCBV和ADC的联合应用有助于PCNSL和GBM的鉴别。

相似文献

1
Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.原发性中枢神经系统淋巴瘤与胶质母细胞瘤的鉴别:灌注加权和扩散加权磁共振成像的联合应用
World Neurosurg. 2018 Apr;112:e1-e6. doi: 10.1016/j.wneu.2017.10.141. Epub 2018 Feb 13.
2
Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.利用肿瘤核心区和瘤周区的多参数灌注及扩散磁共振成像鉴别多形性胶质母细胞瘤、转移瘤和原发性中枢神经系统淋巴瘤——探寻一种实用方法
PLoS One. 2018 Jan 17;13(1):e0191341. doi: 10.1371/journal.pone.0191341. eCollection 2018.
3
Differentiating Primary Central Nervous System Lymphomas From Glioblastomas and Inflammatory Demyelinating Pseudotumor Using Relative Minimum Apparent Diffusion Coefficients.利用相对最小表观扩散系数鉴别原发性中枢神经系统淋巴瘤与胶质母细胞瘤及炎性脱髓鞘假瘤
J Comput Assist Tomogr. 2017 Nov/Dec;41(6):904-909. doi: 10.1097/RCT.0000000000000636.
4
Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.动态对比增强磁共振成像在鉴别胶质母细胞瘤、原发性中枢神经系统淋巴瘤和脑转移瘤中的应用价值。
Eur J Radiol. 2016 Oct;85(10):1722-1727. doi: 10.1016/j.ejrad.2016.07.005. Epub 2016 Jul 15.
5
Differentiating primary central nervous system lymphoma from glioblastoma by time-dependent diffusion using oscillating gradient.利用时变弥散对原发性中枢神经系统淋巴瘤和胶质母细胞瘤进行区分:应用震荡梯度。
Cancer Imaging. 2023 Nov 30;23(1):114. doi: 10.1186/s40644-023-00639-7.
6
Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.基于多参数成像的淋巴瘤与胶质母细胞瘤鉴别:利用T1灌注、扩散及磁敏感加权磁共振成像
Clin Radiol. 2018 Nov;73(11):986.e7-986.e15. doi: 10.1016/j.crad.2018.07.107. Epub 2018 Sep 7.
7
Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.原发性中枢神经系统淋巴瘤和非典型性脑胶质瘤:弥散、灌注和磁化率加权 MR 成像的多参数鉴别诊断。
Radiology. 2014 Sep;272(3):843-50. doi: 10.1148/radiol.14132740. Epub 2014 May 3.
8
Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.利用动态磁敏感对比增强灌注磁共振成像鉴别原发性中枢神经系统淋巴瘤和高级别胶质瘤
Acta Radiol. 2009 Mar;50(2):217-25. doi: 10.1080/02841850802616752.
9
Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.增强型恶性脑肿瘤的灌注与扩散磁共振成像
Eur J Radiol. 2006 Jun;58(3):394-403. doi: 10.1016/j.ejrad.2005.12.032. Epub 2006 Mar 9.
10
Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.扩散加权成像及动态对比增强磁共振成像对原发性中枢神经系统淋巴瘤与胶质母细胞瘤鉴别诊断的定量评估
J Comput Assist Tomogr. 2017 Nov/Dec;41(6):898-903. doi: 10.1097/RCT.0000000000000622.

引用本文的文献

1
Magnetic resonance spectroscopy for enhanced multiparametric MRI characterization of [F]FET PET-negative gliomas.磁共振波谱用于增强[F]FET PET阴性胶质瘤的多参数MRI特征分析
EJNMMI Res. 2025 Apr 7;15(1):37. doi: 10.1186/s13550-025-01224-8.
2
Differentiating primary central nervous system lymphoma from glioblastoma by time-dependent diffusion using oscillating gradient.利用时变弥散对原发性中枢神经系统淋巴瘤和胶质母细胞瘤进行区分:应用震荡梯度。
Cancer Imaging. 2023 Nov 30;23(1):114. doi: 10.1186/s40644-023-00639-7.
3
Differentiation of glioblastoma and primary central nervous system lymphomas using multiparametric diffusion and perfusion magnetic resonance imaging.
利用多参数扩散和灌注磁共振成像鉴别胶质母细胞瘤和原发性中枢神经系统淋巴瘤
Biomed Rep. 2023 Sep 22;19(5):82. doi: 10.3892/br.2023.1664. eCollection 2023 Nov.
4
Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.非增强容积、表观弥散系数和动脉自旋标记在原发性中枢神经系统淋巴瘤和胶质母细胞瘤中的多参数鉴别诊断
Eur Radiol. 2023 Aug;33(8):5357-5367. doi: 10.1007/s00330-023-09681-2. Epub 2023 May 12.
5
Progress of radiological‑pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high‑grade glioma (Review).放射病理学工作流程在原发性中枢神经系统淋巴瘤与高级别胶质瘤鉴别诊断中的研究进展(综述)。
Oncol Rep. 2023 Jan;49(1). doi: 10.3892/or.2022.8457. Epub 2022 Dec 9.
6
Differentiation Between Primary Central Nervous System Lymphoma and Atypical Glioblastoma Based on MRI Morphological Feature and Signal Intensity Ratio: A Retrospective Multicenter Study.基于MRI形态学特征和信号强度比鉴别原发性中枢神经系统淋巴瘤与非典型胶质母细胞瘤:一项回顾性多中心研究
Front Oncol. 2022 Jan 31;12:811197. doi: 10.3389/fonc.2022.811197. eCollection 2022.
7
Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma.基于过滤直方图的磁共振纹理分析(MRTA)用于鉴别原发性中枢神经系统淋巴瘤和胶质母细胞瘤
J Pers Med. 2021 Aug 31;11(9):876. doi: 10.3390/jpm11090876.
8
Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining F-fluorodeoxyglucose Positron Emission Tomography with Arterial Spin Labeling.原发性中枢神经系统淋巴瘤与胶质母细胞瘤的鉴别:结合 F-氟脱氧葡萄糖正电子发射断层扫描与动脉自旋标记的诊断价值。
Neurol Med Chir (Tokyo). 2021 Jun 15;61(6):367-375. doi: 10.2176/nmc.oa.2020-0375. Epub 2021 May 8.
9
Conventional MR and DW imaging findings of cerebellar primary CNS lymphoma: comparison with high-grade glioma.常规磁共振和弥散加权成像在小脑原发性中枢神经系统淋巴瘤中的表现:与高级别胶质瘤的比较。
Sci Rep. 2020 Jun 19;10(1):10007. doi: 10.1038/s41598-020-67080-9.